Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Lixte Biotechnology Holdings, Inc. (LIXT)

NASDAQ

$3.96

$--

(0.00%)

Lixte Biotechnology Holdings, Inc. (LIXT) Live Price Chart

Page last updated: 2026-04-24 13:34:00

Key Market Data

Market Cap	$45.95M
Open	$3.96
High	$71.90
Low	$0.64
Previous Close	$3.98
Price Change	--
Percentage Change	0.00%
Volume	8K

Lixte Biotechnology Holdings, Inc. (LIXT) Stock Price Today

Lixte Biotechnology Holdings, Inc. (LIXT) is currently trading at $3.96 as of 2026-04-24 13:34:00, reflecting a 0.00% move ($-0.00) from the previous close.

In the short term, the stock has returned +33.39% over the past four weeks. Over the last 12 months, Lixte Biotechnology Holdings, Inc. has recorded a +214.89% price change, indicating a Strong performance relative to the broader market.

Lixte Biotechnology Holdings, Inc. (LIXT) 7-Day Stock Price Changes

Over the past seven days, Lixte Biotechnology Holdings, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $3.61 to the latest recorded price of $3.96, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (7,659), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, LIXT has delivered a +33.39% return over the past month and a +214.89% change in the last 12 months, indicating a Strong trend relative to its broader sector peers.

How to Buy Lixte Biotechnology Holdings, Inc. (LIXT)

You can buy and trade LIXT on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for LIXT and Execute Your Trade

Open the trading page, enter LIXT in the search bar, select the amount of LIXT you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Lixte Biotechnology Holdings, Inc. (LIXT)?

Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The company's drug product pipeline is focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. Its product is LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company operates in a single reportable segment, which consists of the development of cancer treatments.

Lixte Biotechnology Holdings, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	3
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.lixte.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Lixte Biotechnology Holdings, Inc.?

The latest trading price for Lixte Biotechnology Holdings, Inc. (Common Stock) is $ 3.96, compared with a previous closing price of $ 3.98. That means the stock has moved 0.00% so far today. Intraday price updates and recent trading activity for LIXT can be tracked on the live chart and quote section on this page.

2.Is Lixte Biotechnology Holdings, Inc. stock going up or down?

Looking at recent performances, LIXT has returned +33.39% over the past month, -4.70% over the last six months and +214.89% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Strong price momentum for Lixte Biotechnology Holdings, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does LIXT currently sit relative to its 52-week high and low?

In the most recent 52-week period, Lixte Biotechnology Holdings, Inc. has traded between a low of $ 0.64 and a high of $ 6.26. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether LIXT is currently nearer the top or the bottom of its one-year trading band.

4.How is Lixte Biotechnology Holdings, Inc. classified by sector and industry?

Lixte Biotechnology Holdings, Inc. is classified in the PHARMACEUTICAL PREPARATIONS sector. In practice, this means Lixte Biotechnology Holdings, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing LIXT’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the PHARMACEUTICAL PREPARATIONS sector could influence Lixte Biotechnology Holdings, Inc.’s performance.

5.Where is Lixte Biotechnology Holdings, Inc. listed and how large is it by market value?

Lixte Biotechnology Holdings, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 45.95M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Lixte Biotechnology Holdings, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does LIXT's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.52 summarises how much profit Lixte Biotechnology Holdings, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Lixte Biotechnology Holdings, Inc.'s financial performance over time?

To follow Lixte Biotechnology Holdings, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how LIXT is performing and how the market is responding.

8.When is Lixte Biotechnology Holdings, Inc. expected to report earnings?

Lixte Biotechnology Holdings, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for LIXT, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Lixte Biotechnology Holdings, Inc.'s earnings reports?

Lixte Biotechnology Holdings, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether LIXT is meeting, beating or missing expectations.

10.How can I stay informed about Lixte Biotechnology Holdings, Inc.'s results and guidance?

You can stay up to date on Lixte Biotechnology Holdings, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for LIXT on this page helps you see how new information is being reflected in the stock.

11.Does Lixte Biotechnology Holdings, Inc. pay a regular cash dividend to its shareholders?

Lixte Biotechnology Holdings, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor LIXT's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for LIXT?

Based on the latest earnings data, LIXT has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Lixte Biotechnology Holdings, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Lixte Biotechnology Holdings, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Lixte Biotechnology Holdings, Inc.?

Lixte Biotechnology Holdings, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is LIXT valued in terms of P/E ratio and EPS?

Lixte Biotechnology Holdings, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.52. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Lixte Biotechnology Holdings, Inc.'s earnings. Comparing LIXT's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

MV Oil Trust

MVO

B&G Foods, Inc.

BGS

Deluxe Corporation

DLX

Norfolk Southern Corp.

NSC

Life Time Group Holdings, Inc.

LTH

Top Gainers

Browse today's leading gainers in the US stock market

MaxLinear, Inc.

MXL

AEye, Inc.

LIDR

Elong Power Holding Limited

ELPW

Cheetah Net Supply Chain Service Inc.

CTNT

FreeCast, Inc.

CAST

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

LIXT-to-USD Calculator

Amount

LIXT

USD

1 LIXT = 3.955 USD